Moe Nina, Krokstad Sidsel, Stenseng Inger Heimdal, Christensen Andreas, Skanke Lars Høsøien, Risnes Kari Ravndal, Nordbø Svein Arne, Døllner Henrik
Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Pediatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
PLoS One. 2017 Jan 17;12(1):e0170200. doi: 10.1371/journal.pone.0170200. eCollection 2017.
It is unclarified as to whether viral co-detection and human metapneumovirus (HMPV) genotypes relate to clinical manifestations in children with HMPV and lower respiratory tract infection (LRTI), and if the clinical course and risk factors for severe LRTI differ between HMPV and respiratory syncytial virus (RSV).
We prospectively enrolled hospitalized children aged <16 years with LRTI from 2006 to 2015. Children were clinically examined, and nasopharyngeal aspirates were analyzed using semi-quantitative, real-time polymerase chain reaction tests for HMPV, RSV and 17 other pathogens. HMPV-positive samples were genotyped.
A total of 171 children had HMPV infection. HMPV-infected children with single virus (n = 106) and co-detections (n = 65) had similar clinical manifestations. No clinical differences were found between HMPV genotypes A (n = 67) and B (n = 80). The HMPV-infected children were older (median 17.2 months) than RSV-infected children (median 7.3 months, n = 859). Among single virus-infected children, no differences in age-adjusted LRTI diagnoses were found between HMPV and RSV. Age was an important factor for disease severity among single virus-infected children, where children <6 months old with HMPV had a milder disease than those with RSV, while in children 12-23 months old, the pattern was the opposite. In multivariable logistic regression analysis for each virus type, age ≥12 months (HMPV), and age <6 months (RSV), prematurity, ≥1 chronic disease and high viral loads of RSV, but not high HMPV viral loads, were risk factors for severe disease.
Among hospitalized children with LRTI, HMPV manifests independently of viral co-detections and HMPV genotypes. Disease severity in HMPV- and RSV-infected children varies in relation to age. A history of prematurity and chronic disease increases the risk of severe LRTI among HMPV- and RSV-infected children.
目前尚不清楚病毒共同检测及人偏肺病毒(HMPV)基因型是否与HMPV感染合并下呼吸道感染(LRTI)患儿的临床表现相关,以及HMPV与呼吸道合胞病毒(RSV)导致严重LRTI的临床病程和危险因素是否存在差异。
我们前瞻性纳入了2006年至2015年期间住院的16岁以下LRTI患儿。对患儿进行临床检查,并使用半定量实时聚合酶链反应检测对鼻咽抽吸物进行分析,以检测HMPV、RSV及其他17种病原体。对HMPV阳性样本进行基因分型。
共有171名儿童感染了HMPV。单一病毒感染(n = 106)和合并感染(n = 65)的HMPV感染儿童临床表现相似。HMPV A基因型(n = 67)和B基因型(n = 80)之间未发现临床差异。HMPV感染儿童(中位年龄17.2个月)比RSV感染儿童(中位年龄7.3个月,n = 859)年龄更大。在单一病毒感染儿童中,HMPV和RSV之间在年龄校正后的LRTI诊断方面未发现差异。年龄是单一病毒感染儿童疾病严重程度的重要因素,6个月以下的HMPV感染儿童病情比RSV感染儿童轻,而在12 - 23个月大的儿童中,情况则相反。在对每种病毒类型进行的多变量逻辑回归分析中,年龄≥12个月(HMPV)、年龄<6个月(RSV)、早产、≥1种慢性病以及RSV的高病毒载量,但不包括HMPV的高病毒载量,是严重疾病的危险因素。
在住院的LRTI患儿中,HMPV的表现与病毒共同检测及HMPV基因型无关。HMPV和RSV感染儿童的疾病严重程度因年龄而异。早产和慢性病病史会增加HMPV和RSV感染儿童发生严重LRTI的风险。